Calculations and Reference Ranges
Clinical Reference Intervals Across Disciplines
On this page
A reference interval belongs to a defined reference population and test system. Age, sex, specimen, analyzer, reagent, altitude, and preanalytical conditions can change its limits. A clinical decision limit serves a different purpose: it marks a risk, classification, or diagnostic threshold chosen from clinical evidence. The distinction matters when a result is compared with a table. CLSI EP28 describes how laboratories establish or verify reference intervals for the population and method in use.1
The tables below are representative examples from named sources. They support comparison across disciplines and do not replace the interval on the performing laboratory’s report. Under CLIA, a laboratory using an unmodified FDA-cleared or approved test system verifies that the manufacturer’s interval is appropriate for its patient population. A modified, noncleared, or laboratory-developed method requires the applicable performance specifications, including an appropriate reference interval, to be established before patient testing.2 The ASCP BOC Examination Reference Ranges remain a separate examination resource.
Chemistry, blood gases, and hematinics
The following chemistry entries illustrate the size of laboratory-to-laboratory differences. The Mayo Clinic Laboratories catalog supplies the named examples. Age partitions apply to several tests, and adult creatinine and blood urea nitrogen (BUN) intervals are sex-specific in that catalog.3
| Test | Population or specimen | Named example interval |
|---|---|---|
| Sodium | Serum or plasma, age 1 year and older | 135–145 mmol/L |
| Potassium | Serum or plasma, age 1 year and older | 3.6–5.2 mmol/L |
| Chloride | Serum or plasma, adult | 98–107 mmol/L |
| Creatinine | Serum, adult male | 0.74–1.35 mg/dL |
| Creatinine | Serum, adult female | 0.59–1.04 mg/dL |
| BUN | Serum, adult male | 8–24 mg/dL |
| BUN | Serum, adult female | 6–21 mg/dL |
Fasting plasma glucose and hemoglobin A1c (HbA1c) are commonly compared with clinical decision limits. In nonpregnant people, fasting plasma glucose of 100 to 125 mg/dL (5.6 to 6.9 mmol/L) or HbA1c of 5.7% to 6.4% (39 to 47 mmol/mol) meets the American Diabetes Association’s 2026 criteria for prediabetes. Those limits should not be relabeled as central 95% reference intervals. An HbA1c of 5.7% converts to about 39 mmol/mol with the NGSP-IFCC master equation and whole-number rounding.4
Arterial blood-gas intervals require the specimen source, inspired oxygen, altitude, temperature handling, and analyzer to be known. One sea-level adult teaching set lists the following values. Venous and capillary samples require their own intervals.5
| Arterial measurement | Named example interval |
|---|---|
| pH | 7.38–7.42 |
| PaCO2 | 38–42 mm Hg (5.1–5.6 kPa) |
| PaO2 | 75–100 mm Hg (10.0–13.3 kPa) |
| SaO2 | 94–100% |
| Calculated HCO3− | 22–28 mmol/L |
Calculated arterial bicarbonate and serum or plasma total CO2 are related measurements from different test systems. Their intervals should remain labeled by specimen and method.
Current Mayo catalog examples for hematinic and hemolysis-related tests also show why one broad adult range can be misleading.6
| Test | Population or specimen | Named example interval or interpretive value |
|---|---|---|
| Haptoglobin | Serum, adult | 30–200 mg/dL (0.3–2.0 g/L) |
| Iron | Serum, adult male | 50–150 µg/dL |
| Iron | Serum, adult female | 35–145 µg/dL |
| Total iron-binding capacity | Serum, adult | 250–400 µg/dL |
| Transferrin saturation | Serum, adult | 14–50% |
| Ferritin | Serum, male age 18 years and older | 31–409 µg/L |
| Ferritin | Serum, female age 18–50 years | 6–175 µg/L |
| Ferritin | Serum, female age 51 years and older | 11–328 µg/L |
| Vitamin B12 | Serum | 180–914 ng/L |
| Folate | Serum | ≥4.0 µg/L suggests adequate stores |
| Plasma-free hemoglobin | EDTA plasma, age 12 months and older | 0.0–15.2 mg/dL |
Ferritin and haptoglobin are acute-phase reactants, so inflammation can change their interpretation. Serum folate below 4.0 µg/L suggests possible deficiency and requires clinical correlation. Red-cell folate is omitted because analytic variability makes serum folate the preferred test in the cited laboratory guidance. Plasma-free hemoglobin requires plasma; clotting makes serum unsuitable for the same interval. The erythrocyte sedimentation rate (ESR) is also method-specific. An OHSU Westergren example uses upper limits of 15 mm/h for males through age 50, 20 mm/h for older males and females through age 50, and 30 mm/h for older females.7
Complete blood count by age and sex
CBC intervals depend on the analyzer and reference population. The table shows selected adult Mayo intervals for one analyzer system. Relative differential percentages and absolute counts have separately derived intervals; the endpoints should not be calculated from each other.8
| Measurement | Adult male | Adult female |
|---|---|---|
| RBC count | 4.35–5.65 × 1012/L | 3.92–5.13 × 1012/L |
| Hemoglobin | 13.2–16.6 g/dL | 11.6–15.0 g/dL |
| Hematocrit | 38.3–48.6% | 35.5–44.9% |
| MCV | 78.2–97.9 fL | 78.2–97.93 fL |
| RDW | 11.8–14.5% | 12.2–16.1% |
| WBC count | 3.4–9.6 × 109/L | 3.4–9.6 × 109/L |
| Platelet count | 135–317 × 109/L | 157–371 × 109/L |
| Absolute neutrophil count | 1.56–6.45 × 109/L | 1.56–6.45 × 109/L |
| Absolute lymphocyte count | 0.95–3.07 × 109/L | 0.95–3.07 × 109/L |
Mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, mean platelet volume, and reticulocyte results require the interval reported for the specific analyzer or assay. Adult nucleated RBCs are generally expected to be absent from peripheral blood. The Red Cell, Reticulocyte, and Absolute Count Calculations topic covers the related formulas.
Pediatric partitions are narrower than the broad age bands used in many teaching tables. The same Mayo catalog separates the first 14 days, several intervals during early infancy, childhood, and adolescence. Selected values show the developmental pattern.8
| Measurement | Age, male | Named example interval |
|---|---|---|
| Hemoglobin | 0–14 days | 13.9–19.1 g/dL |
| Hemoglobin | 5–7 weeks | 8.9–12.7 g/dL |
| Hemoglobin | 6–8 years | 11.5–14.3 g/dL |
| Hemoglobin | Adult | 13.2–16.6 g/dL |
| MCV | 0–14 days | 91.3–103.1 fL |
| MCV | 5–7 weeks | 84.3–94.2 fL |
| MCV | 6–11 years | 77.8–91.1 fL |
| MCV | Adult | 78.2–97.9 fL |
| WBC count | 0–14 days | 8.0–15.4 × 109/L |
| WBC count | 5–7 weeks | 8.1–15.0 × 109/L |
| WBC count | 6–17 years | 3.8–10.4 × 109/L |
| WBC count | Adult | 3.4–9.6 × 109/L |
| Platelet count | 0–14 days | 218–419 × 109/L |
| Platelet count | 5–7 weeks | 229–562 × 109/L |
| Platelet count | 6–9 years | 187–400 × 109/L |
| Platelet count | Adult | 135–317 × 109/L |
Hemoglobin and MCV are high soon after birth, fall during early infancy, and rise toward later-childhood and adult intervals. WBC, platelet, RDW, reticulocyte, and nucleated-RBC intervals also change after birth. Gestational age and postnatal age matter in neonates. A pediatric result should be compared with the exact age and sex partition on its report.
Hemoglobin fractions and bone marrow
Hemoglobin fractions change rapidly during infancy. The capillary-electrophoresis and HPLC example below comes from one current Mayo assay. Transfusion history, gestational age, postnatal age, and a hemoglobin variant can alter the pattern.9
| Fraction | Age 0–30 days | Age 3–5 months | Age 24 months and older |
|---|---|---|---|
| HbA | 5.9–77.2% | 54.7–97.1% | 95.8–98.0% |
| HbA2 | 0.0–2.1% | 1.3–3.1% | 2.0–3.3% |
| HbF | 22.8–92.0% | 1.6–42.2% | 0.0–0.9% |
Bone-marrow differentials depend on aspirate quality, dilution with peripheral blood, cell-category definitions, the number of cells counted, and observer classification. A study of 236 healthy adult donors used first-pull aspirates and 600-cell differential counts to derive the following 95% reference intervals.10
| Marrow category | Study interval |
|---|---|
| Erythroblasts, total | 15.8–46.2% |
| Proerythroblasts | 0.0–3.0% |
| Basophilic erythroblasts | 0.5–13.5% |
| Polychromatophilic erythroblasts | 7.8–34.5% |
| Orthochromatic erythroblasts | 0.5–16.5% |
| Granulocytes, total | 34.8–66.3% |
| Myeloblasts | 0.0–5.0% |
| Promyelocytes | 0.0–5.5% |
| Myelocytes | 5.8–24.0% |
| Metamyelocytes | 1.0–12.0% |
| Band neutrophils | 6.5–26.2% |
| Segmented neutrophils | 2.5–19.7% |
| Eosinophils, all stages | 0.5–7.0% |
| Basophils and mast cells | 0.0–1.5% |
| Monocytes | 0.0–6.0% |
| Lymphocytes | 5.5–23.2% |
| Plasma cells | 0.0–7.0% |
| Myeloid-to-erythroid ratio | 0.8–4.1 |
The study classified one to three megakaryocytes per low-power field as its expected finding. Laboratories may use qualitative or semiquantitative megakaryocyte categories, so this count should remain attached to the study method.
Developmental hemostasis and coagulation
Coagulation intervals change during infancy and childhood. Vitamin K-dependent factors II, VII, IX, and X, antithrombin, protein C, and protein S are lower in early life in many assay systems. Factor VIII and von Willebrand factor behave differently. Prothrombin time may resemble an adult interval while activated partial thromboplastin time is longer in young children. Reagent and analyzer effects can be as important as age, so each laboratory needs age-appropriate intervals for its system.11
One current Mayo method uses the following examples. They show assay context and should not be transferred as a single composite coagulation panel.12
| Assay | Population | Named example interval |
|---|---|---|
| Factor VIII activity | Adult | 55–200% |
| Factor IX activity | Age 6 months and older | 65–140% |
| Antithrombin activity | Adult | 80–130% |
| Protein C activity | Adult | 70–150% |
| von Willebrand factor antigen | Common assay interval | 55–200% |
| von Willebrand factor activity | Common assay interval | 55–200% |
Factor activity reported as a percentage and as U/dL has the same numerical value only when the calibration assigns 100% activity to 100 U/dL. D-dimer also requires its assay and unit convention, including fibrinogen-equivalent units or D-dimer units. Activated protein C resistance, antiphospholipid antibody, factor XIII, prekallikrein, high-molecular-weight kininogen, plasminogen-activator inhibitor 1, and homocysteine cutoffs are method- or decision-specific. The report and current interpretive procedure supply the applicable limits.
Cerebrospinal fluid
CSF intervals depend on age, collection site, concurrent blood results, and method. In a study of febrile infants without bacterial meningitis, the 95th-percentile lumbar CSF WBC counts were 19 cells/µL at age 0 to 28 days and 9 cells/µL at age 29 to 56 days. These study limits should stay attached to that population rather than serve as universal neonatal intervals.13
Current Mayo and Children’s Minnesota laboratory references provide the following examples for older patients. CSF glucose is interpreted against a blood glucose collected at about the same time, and is commonly about 60% of the blood value.14
| Measurement | Named example or expected finding |
|---|---|
| Appearance | Clear and colorless |
| Glucose | About 60% of concurrent blood glucose |
| Total protein, age 12 months and older | 0–35 mg/dL |
| Albumin | 0–27 mg/dL |
| IgG | 0–8.1 mg/dL |
| RBCs after a nontraumatic lumbar puncture | None expected |
Differential percentages are unstable when only a few cells are present. Mononuclear cells usually predominate in older children and adults; neonatal specimens can contain more neutrophils. An increased CSF eosinophil count prompts investigation for parasitic or fungal infection and other causes, including a shunt reaction, medication, blood contamination, or malignancy. Interpretation uses the absolute count, collection site, and clinical setting. The Body-Fluid Cell Counts and Cerebrospinal Fluid topic covers specimen handling and detailed interpretation.
Pleural and peritoneal fluid criteria
Light’s criteria classify a pleural effusion as an exudate when at least one of these conditions is met:15
- pleural-fluid total protein ÷ serum total protein >0.5
- pleural-fluid lactate dehydrogenase (LDH) ÷ serum LDH >0.6
- pleural-fluid LDH > two-thirds of the serum LDH upper reference limit
Use serum and pleural-fluid results collected close together. Keep full precision while comparing a ratio with its cutoff, then round the displayed result. For example, pleural-fluid protein of 3.4 g/dL and serum protein of 6.0 g/dL give:
protein ratio = 3.4 ÷ 6.0 = 0.5666…, displayed as 0.57
The unrounded ratio exceeds 0.5, so the protein criterion is met. Light’s criteria apply to pleural fluid. Pericardial and other serous fluids require their own clinical and laboratory criteria.
The serum-ascites albumin gradient (SAAG) supports the etiologic classification of ascites:
SAAG (g/dL) = serum albumin (g/dL) − ascitic-fluid albumin (g/dL)
The serum and ascitic-fluid specimens should be collected at about the same time. A SAAG of at least 1.1 g/dL supports portal hypertension in the appropriate clinical setting; a lower value suggests another mechanism.16 If serum albumin is 3.2 g/dL and ascitic-fluid albumin is 1.7 g/dL:
SAAG = 3.2 − 1.7 = 1.5 g/dL
The result meets the 1.1 g/dL decision criterion. It is a classification result, rather than a reference interval for a healthy population.
Pleural-fluid triglyceride above 110 mg/dL (about 1.2 mmol/L) supports a chylous effusion, and demonstration of chylomicrons establishes its chylous nature. Pleural-fluid cholesterol above 200 mg/dL (about 5.2 mmol/L), absent chylomicrons, and cholesterol crystals support a pseudochylous effusion. Thresholds for peritoneal fluid differ, and appearance alone cannot make the distinction.17
Synovial fluid
One current laboratory reference describes noninflammatory synovial fluid as clear, colorless to pale yellow, highly viscous, and free of crystals. Appearance and viscosity are qualitative observations. Aspirated volume and RBC count depend strongly on collection, and the traditional string test is a subjective viscosity estimate. The following cell-count examples come from one current Mayo body-fluid method.18
| Measurement | Named synovial-fluid example |
|---|---|
| Total nucleated cell count | <150 cells/µL |
| Neutrophils | <25% |
| Lymphocytes | <75% |
| Monocytes and macrophages | <70% |
| Crystals | None detected |
Mononuclear cells predominate in a low-cellularity sample. A traumatic collection can add RBCs and peripheral leukocytes. Protein, hyaluronate, glucose, uric acid, and lactate results are method-specific. When synovial glucose is used, a serum or plasma specimen collected near the fluid sample provides the comparison.
Urine and fecal findings
Hydration and renal concentrating ability produce a wide physiologic spread in urine concentration. Current Mayo refractometry and freezing-point-osmometry examples include specific gravity of 1.002 to 1.030, urine pH of 4.5 to 8.0, osmolality of 50 to 750 mOsm/kg for infants younger than 12 months, and 150 to 1150 mOsm/kg for patients age 12 months and older.19 Protein, glucose, ketones, bilirubin, nitrite, and leukocyte esterase are expected to be negative on a routine reagent strip, subject to the strip’s detection limits and interferences. Urobilinogen is usually low or trace. Microscopy intervals depend on centrifugation, volume, field size, imaging system, and reporting convention. A few hyaline casts can occur with dehydration or exercise; granular casts require morphologic and clinical interpretation. The Specific Gravity and Osmolality and Urine Microscopy topics cover these method effects. The Urine Reagent-Strip Chemistry and Confirmatory Testing topic covers strip reactions, detection limits, and confirmatory methods.
Twenty-four-hour urine volume and osmolality are interpreted with intake, fluid losses, collection duration, and collection completeness. The Timed Urine and Renal Clearance Calculations topic covers the required time and volume arithmetic.
Formed brown stool and absent fecal leukocytes are usual qualitative findings. An immunochemical fecal occult-blood reference result is negative, with method-specific detection limits. For quantitative fecal fat, one current Mayo method requires a 100 to 150 g daily fat intake and a 24- to 96-hour collection. Its adult timed interval is 2 to 7 g fat per 24 hours. The same catalog reports 0% to 19% fat for a random stool method. The timed result is normalized to 24 hours, and the test does not identify the cause of fat malabsorption by itself.20
References
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. 3rd ed. CLSI guideline EP28. Clinical and Laboratory Standards Institute; 2010. Accessed August 30, 2026.
- Code of Federal Regulations. 42 CFR § 493.1253(b)(1)(ii), (b)(2)(vi). Accessed August 30, 2026.
- Mayo Clinic Laboratories. Comprehensive metabolic panel, serum; creatinine, serum; blood urea nitrogen, serum. Accessed August 30, 2026.
- American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(suppl 1):S27-S49. doi:10.2337/dc26-S002. National Glycohemoglobin Standardization Program. IFCC standardization of HbA1c. Accessed August 30, 2026.
- MedlinePlus. Blood gases. Reviewed August 19, 2024. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Haptoglobin, serum; iron and total iron-binding capacity, serum; ferritin, serum; vitamin B12 assay, serum; folate, serum; folate, red blood cell; plasma-free hemoglobin, plasma. Accessed August 30, 2026.
- Oregon Health & Science University. Erythrocyte sedimentation rate. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Complete blood cell count with differential, blood. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Hemoglobin electrophoresis evaluation, blood. Accessed August 30, 2026.
- Parmentier S, Krämer M, Weller S, et al. Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors. Ann Hematol. 2020;99(12):2723-2729. doi:10.1007/s00277-020-04255-4.
- Toulon P. Developmental hemostasis: laboratory and clinical implications. Int J Lab Hematol. 2016;38(suppl 1):66-77. doi:10.1111/ijlh.12531.
- Mayo Clinic Laboratories. Factor VIII activity, plasma; factor IX activity, plasma; antithrombin activity, plasma; protein C activity, plasma; von Willebrand disease profile, plasma. Accessed August 30, 2026.
- Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics. 2010;125(2):257-264. doi:10.1542/peds.2009-1181.
- Mayo Clinic Laboratories. Glucose, spinal fluid; total protein, spinal fluid; IgG and albumin, spinal fluid. Children's Minnesota. CSF count and differential. Accessed August 30, 2026.
- Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507-513. doi:10.7326/0003-4819-77-4-507.
- Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014-1048. doi:10.1002/hep.31884.
- Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax. 2023;78(suppl 3):s1-s42. doi:10.1136/thorax-2022-219784. Mayo Clinic Laboratories. Chylomicron screen, body fluid. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Cell count and differential, body fluid. Oregon Health & Science University. Synovial fluid examination. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Specific gravity, urine; osmolality, urine; pH, urine. Accessed August 30, 2026.
- Mayo Clinic Laboratories. Fat, feces; Occult blood, feces. Accessed August 30, 2026.